Nebula Research & Development LLC Has $1.92 Million Stake in Elevance Health, Inc. (NYSE:ELV)

Nebula Research & Development LLC grew its stake in Elevance Health, Inc. (NYSE:ELV - Free Report) by 537.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,213 shares of the company's stock after buying an additional 4,395 shares during the period. Nebula Research & Development LLC's holdings in Elevance Health were worth $1,923,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ELV. Mutual Advisors LLC grew its position in shares of Elevance Health by 2.5% in the fourth quarter. Mutual Advisors LLC now owns 2,163 shares of the company's stock valued at $833,000 after purchasing an additional 52 shares during the last quarter. Czech National Bank increased its position in Elevance Health by 6.5% in the 4th quarter. Czech National Bank now owns 50,286 shares of the company's stock worth $18,551,000 after buying an additional 3,049 shares during the period. Diversified Trust Co lifted its holdings in shares of Elevance Health by 13.7% during the fourth quarter. Diversified Trust Co now owns 22,576 shares of the company's stock worth $8,328,000 after buying an additional 2,725 shares during the last quarter. JB Capital LLC boosted its position in shares of Elevance Health by 597.2% in the fourth quarter. JB Capital LLC now owns 9,384 shares of the company's stock valued at $3,462,000 after acquiring an additional 8,038 shares during the period. Finally, Tidal Investments LLC grew its stake in shares of Elevance Health by 60.6% in the third quarter. Tidal Investments LLC now owns 10,485 shares of the company's stock worth $5,452,000 after acquiring an additional 3,956 shares during the last quarter. Institutional investors own 89.24% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Argus set a $465.00 price objective on shares of Elevance Health in a report on Friday, April 25th. Truist Financial raised their price objective on Elevance Health from $480.00 to $510.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Robert W. Baird restated a "neutral" rating and set a $529.00 price objective (down from $625.00) on shares of Elevance Health in a research report on Tuesday, April 15th. Stephens cut Elevance Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $520.00 to $440.00 in a research report on Wednesday, January 22nd. Finally, StockNews.com raised shares of Elevance Health from a "hold" rating to a "buy" rating in a report on Thursday, March 20th. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, Elevance Health has an average rating of "Moderate Buy" and an average price target of $510.38.

Elevance Health Price Performance

Shares of Elevance Health stock traded down $5.59 during trading on Thursday, reaching $414.99. The company's stock had a trading volume of 455,730 shares, compared to its average volume of 1,460,165. Elevance Health, Inc. has a one year low of $362.21 and a one year high of $567.26. The stock has a 50-day moving average price of $421.60 and a two-hundred day moving average price of $406.82. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $93.76 billion, a P/E ratio of 16.18, a price-to-earnings-growth ratio of 1.18 and a beta of 0.77.

Elevance Health (NYSE:ELV - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The company reported $11.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.60 by $1.37. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. The company had revenue of $48.77 billion for the quarter, compared to analyst estimates of $46.26 billion. As a group, sell-side analysts anticipate that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Tuesday, June 10th will be paid a $1.71 dividend. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $6.84 annualized dividend and a dividend yield of 1.65%. Elevance Health's dividend payout ratio (DPR) is currently 26.69%.

Insider Activity

In other Elevance Health news, CFO Mark Kaye sold 4,588 shares of the company's stock in a transaction on Thursday, April 24th. The shares were sold at an average price of $424.82, for a total transaction of $1,949,074.16. Following the completion of the sale, the chief financial officer now owns 18,977 shares in the company, valued at approximately $8,061,809.14. The trade was a 19.47 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the firm's stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $396.30, for a total value of $1,388,635.20. Following the completion of the transaction, the executive vice president now owns 10,116 shares in the company, valued at $4,008,970.80. This represents a 25.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,535 shares of company stock valued at $3,521,612 over the last 90 days. 0.29% of the stock is owned by company insiders.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.